cyclosporine has been researched along with Panuveitis in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 7 (53.85) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Nihei, R; Nishio, Y; Sato, T; Sora, D; Takeuchi, M | 1 |
Edwards Mayhew, RG; Leslie, L; Li, T; McCann, P; Palestine, AG; Strong Caldwell, A | 1 |
Atalay, E; Özkök, A; Özyazgan, Y; Uçar, D; Yıldırım, Y | 1 |
Bascherini, V; Cantarini, L; Caso, F; Costa, L; Franceschini, R; Latronico, E; Rigante, D; Vitale, A | 1 |
Krause, L | 1 |
Cruysberg, LP; Csaky, KG; Edelhauser, HF; Gilger, BC; Harrington, SM; Hayat, M; Kim, H; Kim, J; Kim, S; Lee, SS; Murray, PR; Robinson, MR; Salmon, JH; Wilkie, DA; Yuan, P | 1 |
Balaton, G; Barabasi, Z; Kiss, E; Vajo, Z | 1 |
Ashton, P; Cousins, SW; Gallemore, RP; Jaffe, GJ; Wang, XC; Yang, CS | 1 |
Nussenblatt, RB; Walton, RC; Whitcup, SM | 1 |
Foster, CS; Gion, N; Stavrou, P | 1 |
Brown, AM; Murray, PI; Ramchandani, M; Rippin, JW | 1 |
Beiran, I; Miller, B; Scharf, J; Seider, N | 1 |
Baltatzis, S; Ekong, A; Foster, CS; Michel, SS | 1 |
2 review(s) available for cyclosporine and Panuveitis
Article | Year |
---|---|
Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.
Topics: Adult; Antirheumatic Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Macular Edema; Methotrexate; Mycophenolic Acid; Panuveitis; Steroids; Tacrolimus | 2022 |
[Adamantiades-Behcet's disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Etanercept; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Panuveitis; Receptors, Tumor Necrosis Factor; Retinal Vasculitis; Tumor Necrosis Factor-alpha | 2005 |
1 trial(s) available for cyclosporine and Panuveitis
Article | Year |
---|---|
A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis.
Topics: Absorbable Implants; Animals; Cyclosporine; Drug Delivery Systems; Feasibility Studies; Horse Diseases; Horses; Humans; Immunosuppressive Agents; Leptospira interrogans; Microbial Sensitivity Tests; Panuveitis; Permeability; Recurrence; Sclera; Treatment Outcome | 2006 |
10 other study(ies) available for cyclosporine and Panuveitis
Article | Year |
---|---|
Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine.
Topics: BNT162 Vaccine; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Cyclosporine; Epitopes; HLA-DR4 Antigen; Humans; Male; Middle Aged; Panuveitis; RNA, Messenger; SARS-CoV-2; Uveomeningoencephalitic Syndrome | 2022 |
An exceptional case of full-thickness macular hole closure in a patient with Behçet disease.
Topics: Administration, Oral; Administration, Topical; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Panuveitis; Recombinant Proteins; Remission, Spontaneous; Retinal Perforations; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2014 |
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD20; Audiometry; Cyclosporine; Dexamethasone; Female; Hearing Loss; Hearing Loss, Sensorineural; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Panuveitis; Prednisolone; Prednisone; Prognosis; Recurrence; Remission Induction; Rituximab; Uveitis; Uveomeningoencephalitic Syndrome | 2015 |
Cutaneous granuloma and uveitis caused by a tattoo.
Topics: Adult; Anti-Inflammatory Agents; Cobalt; Combined Modality Therapy; Cyclosporine; Diagnosis, Differential; Granuloma; Humans; Iridocyclitis; Male; Ophthalmoscopy; Panuveitis; Prednisolone; Tattooing | 2008 |
Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.
Topics: Animals; Anterior Eye Segment; Aqueous Humor; CD4-Positive T-Lymphocytes; Chronic Disease; Cyclosporine; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Electroretinography; Flow Cytometry; Immunosuppressive Agents; Mycobacterium tuberculosis; Panuveitis; Rabbits; Retina; Tuberculin; Vitreous Body | 1998 |
Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents.
Topics: Adolescent; Child; Creatinine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Panuveitis; Retrospective Studies; Safety; Treatment Outcome; Uveitis, Intermediate; Vision Disorders; Visual Acuity | 1998 |
Immunomodulatory therapy for chronic tubulointerstitial nephritis-associated uveitis.
Topics: Adolescent; Adult; Azathioprine; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Nephritis, Interstitial; Panuveitis; Retrospective Studies; Secondary Prevention; Uveitis, Anterior; Visual Acuity | 2000 |
Labial adenocarcinoma after treatment with cyclosporin a in a patient with panuveitis.
Topics: Adenocarcinoma; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lip Neoplasms; Panuveitis; Prednisolone; Retinal Diseases; Retinal Vessels; Vasculitis | 2000 |
Intravenous immunoglobulin therapy for resistant ocular Behçet's disease.
Topics: Adolescent; Adult; Behcet Syndrome; Cyclosporine; Drug Administration Schedule; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Panuveitis; Treatment Failure; Treatment Outcome | 2001 |
Multifocal choroiditis and panuveitis: immunomodulatory therapy.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Choroiditis; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Panuveitis; Retrospective Studies; Steroids; Treatment Outcome; Visual Acuity | 2002 |